A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.
The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.
The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.
It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).
.@DoHSocial has partnered with Swiss healthcare company @Roche to provide a new Covid-19 medication, approved for emergency use, to treat mild to moderate Covid-19 cases and those who have had direct contact with a positive case.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) December 1, 2021
Read more: https://t.co/vGQXyUvhGB pic.twitter.com/Yj9JxVgemP
അബുദാബിയിലെ അൽ ബഹ്യ പ്രദേശത്ത് ഒരു സിവിലിയൻ വാഹനത്തിൽ മിസൈൽ പതിച്ച് ഒരാൾ മരിച്ചു
തിങ്കളാഴ്ച ഫുജേറയിലും ദുബായിലും ഡ്രോൺ ആക്രമണമുണ്ടായി
No injuries as authorities contain fire at Fujairah Oil Industry Zone
One dead after missile falls on vehicle in Abu Dhabi's Al Bahyah
Dubai closes some routes heading to airport road
Dubai flights to resume gradually on Monday
Emirates to resume flights on Monday
UAE responds to incoming Iranian missile, drone threats on Monday
